Use of fertility drugs and risk of ovarian cancer

Hum Reprod. 2001 Jul;16(7):1372-5. doi: 10.1093/humrep/16.7.1372.

Abstract

Background: The potential association between fertility drugs and risk of ovarian cancer has been analysed using data from a case-control study conducted between January 1992 and September 1999 in four Italian areas.

Methods: Cases were 1031 women (median age 56, range 18-79 years) with incident, histologically confirmed epithelial ovarian cancer. Controls were 2411 women (median age 57, range 17-79 years) residing in the same geographical areas and admitted to the same network of hospitals for cases for a wide spectrum of acute, non neoplastic, non hormone-related conditions.

Results: A total of 15 cases and 26 controls reported use of fertility drugs. The corresponding odds ratio (OR) was 1.3 (95% confidence interval 0.7-2.5). The OR was 1.2 for women reporting last use <25 years before interview and 1.3 for >25 years.

Conclusions: Considering calendar year at use, the OR was non-significantly above unity for women reporting fertility drug use after 1970. The OR was 0.6 among nulliparous women and 1.9 among parous ones.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Case-Control Studies
  • Educational Status
  • Female
  • Fertility Agents / adverse effects*
  • Humans
  • Middle Aged
  • Odds Ratio
  • Ovarian Neoplasms / chemically induced
  • Ovarian Neoplasms / epidemiology*
  • Ovarian Neoplasms / genetics
  • Parity
  • Risk Factors

Substances

  • Fertility Agents